June 24, 2008 – Teva Pharmaceuticals is pleased to announce the introduction and availability of Ramipril Capsules. This product is AB rated and bioequivalent to Altace®* Capsules. Ramipril Capsules are available in 2.5 mg, 5 mg, and 10 mg strengths, in bottle sizes of 100.
“Generic pharmaceuticals are playing an increasingly important role in healthcare cost containment,” states John Denman, V.P. Sales and Marketing. “Teva Pharmaceuticals continues to lead the way with timely new product launches.”
No comments:
Post a Comment